Cullinan Therapeutics Common
(CGEM)
|
20.7 |
$133M |
|
7.6M |
17.44 |
Insmed Incorporated Common
(INSM)
|
6.4 |
$41M |
|
615k |
67.00 |
Olema Pharmaceuticals Common
(OLMA)
|
4.5 |
$29M |
|
2.7M |
10.82 |
iTeos Therapeutics Common
(ITOS)
|
4.0 |
$26M |
|
1.7M |
14.84 |
Crinetics Pharmaceuticals Common
(CRNX)
|
3.9 |
$25M |
|
557k |
44.79 |
Madrigal Pharmaceuticals Common
(MDGL)
|
3.1 |
$20M |
|
71k |
280.16 |
Iovance Biotherapeutics Common
(IOVA)
|
2.9 |
$19M |
|
2.4M |
8.02 |
Natera Common
(NTRA)
|
2.9 |
$19M |
|
175k |
108.29 |
Mirum Pharmaceuticals Common
(MIRM)
|
2.6 |
$17M |
|
493k |
34.19 |
Ultragenyx Pharmaceutical Common
(RARE)
|
2.4 |
$16M |
|
381k |
41.10 |
Moonlake Immunotherapeutics Class A Ord
(MLTX)
|
2.3 |
$15M |
|
343k |
43.97 |
Guardant Health Common
(GH)
|
2.2 |
$14M |
|
500k |
28.88 |
Disc Medicine Common
(IRON)
|
2.1 |
$14M |
|
306k |
45.07 |
Alkermes Common
(ALKS)
|
2.1 |
$13M |
|
558k |
24.10 |
Edgewise Therapeutics Common
(EWTX)
|
2.1 |
$13M |
|
741k |
18.01 |
ALX Oncology Holdings Common
(ALXO)
|
2.0 |
$13M |
|
2.2M |
6.03 |
Morphic Holding Common
(MORF)
|
2.0 |
$13M |
|
369k |
34.07 |
Lantheus Holdings Common
(LNTH)
|
1.9 |
$12M |
|
150k |
80.29 |
Revolution Medicines Common
(RVMD)
|
1.7 |
$11M |
|
289k |
38.81 |
Avadel Pharmaceuticals Sponsored ADR
|
1.7 |
$11M |
|
783k |
14.06 |
Xeris Biopharma Holdings Common
(XERS)
|
1.7 |
$11M |
|
4.8M |
2.25 |
Axsome Therapeutics Common
(AXSM)
|
1.7 |
$11M |
|
132k |
80.50 |
Kalvista Pharmaceuticals Common
(KALV)
|
1.6 |
$10M |
|
882k |
11.78 |
Intellia Therapeutics Common
(NTLA)
|
1.5 |
$9.9M |
|
444k |
22.38 |
Hillevax Common
(HLVX)
|
1.4 |
$9.3M |
|
645k |
14.46 |
Akero Therapeutics Common
(AKRO)
|
1.4 |
$9.1M |
|
386k |
23.46 |
89Bio Common
(ETNB)
|
1.4 |
$9.0M |
|
1.1M |
8.01 |
Fulcrum Therapeutics Common
(FULC)
|
1.4 |
$9.0M |
|
1.4M |
6.20 |
Sutro Biopharma Common
(STRO)
|
1.4 |
$8.9M |
|
3.0M |
2.93 |
Scholar Rock Holding Corp Common
(SRRK)
|
1.3 |
$8.6M |
|
1.0M |
8.33 |
Relay Therapeutics Common
(RLAY)
|
1.3 |
$8.3M |
|
1.3M |
6.52 |
Cartesian Therapeutics Common
(RNAC)
|
1.1 |
$7.0M |
|
260k |
27.01 |
Regenxbio Common
(RGNX)
|
1.0 |
$6.5M |
|
557k |
11.70 |
Viking Therapeutics Common
(VKTX)
|
1.0 |
$6.3M |
|
119k |
53.01 |
Zentalis Pharmaceuticals Common
(ZNTL)
|
0.9 |
$5.9M |
|
1.5M |
4.09 |
Werewolf Therapeutics Common
(HOWL)
|
0.9 |
$5.8M |
|
2.4M |
2.44 |
Repare Therapeutics Common
(RPTX)
|
0.8 |
$5.4M |
|
1.6M |
3.30 |
Avidity Biosciences Common
(RNA)
|
0.8 |
$5.1M |
|
125k |
40.85 |
Compass Therapeutics Common
(CMPX)
|
0.8 |
$5.0M |
|
5.0M |
1.00 |
Adaptimmune Therapeutics Sponsored ADR
(ADAP)
|
0.8 |
$5.0M |
|
5.1M |
0.97 |
Immatics NV Common
(IMTX)
|
0.8 |
$4.9M |
|
418k |
11.62 |
Trevi Therapeutics Common
(TRVI)
|
0.7 |
$4.5M |
|
1.5M |
2.98 |
Verve Therapeutics Common
(VERV)
|
0.5 |
$3.1M |
|
638k |
4.88 |
Allakos Common
(ALLK)
|
0.1 |
$345k |
|
345k |
1.00 |